Trial intelligence / Profile preview

DOA study of preoperative duloxetine before hip or knee arthroplasty

NL-OMON25835Not yet recruiting

Sponsor
University Medical Center Groningen
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of duloxetine in osteoarthritis (OA) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Degree of pain relief 6 months after total hip or knee arthroplasty. Planned start Sep 2014; status: not yet recruiting.

02

Drugs

duloxetine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NL-OMON25835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call